Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaco Voorham

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Medical Care|December 11, 2012
Association between performance measures and glycemic control among patients with diabetes in a community-wide primary care cohortGrigory Sidorenkov, Jaco Voorham, Flora M Haaijer-Ruskamp, et al.
Plos One|November 9, 2013
Do treatment quality indicators predict cardiovascular outcomes in patients with diabetes?Grigory Sidorenkov, Jaco Voorham, Dick de Zeeuw, et al.
BMJ Quality & Safety|February 7, 2013
Treatment quality indicators predict short-term outcomes in patients with diabetes: a prospective cohort study using the GIANTT databaseGrigory Sidorenkov, Jaco Voorham, Dick de Zeeuw, et al.
Healthcare (Basel, Switzerland)|June 28, 2023
The Relationship between Nursing Practice Environment and Pressure Ulcer Care Quality in Portugal's Long-Term Care UnitsKatia Furtado, Jaco Voorham, Paulo Infante, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 25, 2012
Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohortMerel E Hellemons, Petra Denig, Dick de Zeeuw, et al.
Diabetes Care|December 12, 2007
Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetesJaco Voorham, Flora M Haaijer-Ruskamp, Ronald P Stolk, et al.
Clinical Therapeutics|March 15, 2011
Medication adherence affects treatment modifications in patients with type 2 diabetesJaco Voorham, Flora M Haaijer-Ruskamp, Bruce H R Wolffenbuttel, et al.
Pharmacoepidemiology and Drug Safety|December 5, 2009
A systematic literature review: prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk managementLiana Martirosyan, Jaco Voorham, Flora M Haaijer-Ruskamp, et al.
Journal of Asthma and Allergy|September 15, 2018
Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational studyDavid B Price, Frank Trudo, Jaco Voorham, et al.
Pragmatic and Observational Research|May 2, 2017
Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort studyJaco Voorham, Bernard Vrijens, Job Fm van Boven, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Medical Care|December 11, 2012
Association between performance measures and glycemic control among patients with diabetes in a community-wide primary care cohortGrigory Sidorenkov, Jaco Voorham, Flora M Haaijer-Ruskamp, et al.
Plos One|November 9, 2013
Do treatment quality indicators predict cardiovascular outcomes in patients with diabetes?Grigory Sidorenkov, Jaco Voorham, Dick de Zeeuw, et al.
BMJ Quality & Safety|February 7, 2013
Treatment quality indicators predict short-term outcomes in patients with diabetes: a prospective cohort study using the GIANTT databaseGrigory Sidorenkov, Jaco Voorham, Dick de Zeeuw, et al.
Healthcare (Basel, Switzerland)|June 28, 2023
The Relationship between Nursing Practice Environment and Pressure Ulcer Care Quality in Portugal's Long-Term Care UnitsKatia Furtado, Jaco Voorham, Paulo Infante, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 25, 2012
Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohortMerel E Hellemons, Petra Denig, Dick de Zeeuw, et al.
Diabetes Care|December 12, 2007
Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetesJaco Voorham, Flora M Haaijer-Ruskamp, Ronald P Stolk, et al.
Clinical Therapeutics|March 15, 2011
Medication adherence affects treatment modifications in patients with type 2 diabetesJaco Voorham, Flora M Haaijer-Ruskamp, Bruce H R Wolffenbuttel, et al.
Pharmacoepidemiology and Drug Safety|December 5, 2009
A systematic literature review: prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk managementLiana Martirosyan, Jaco Voorham, Flora M Haaijer-Ruskamp, et al.
Journal of Asthma and Allergy|September 15, 2018
Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational studyDavid B Price, Frank Trudo, Jaco Voorham, et al.
Pragmatic and Observational Research|May 2, 2017
Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort studyJaco Voorham, Bernard Vrijens, Job Fm van Boven, et al.
Pageof 4